Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Biliary Tract Diseases

  Free Subscription


Articles published in Dig Dis

Retrieve available abstracts of 29 articles:
HTML format
Text format



Single Articles


    February 2019
  1. HARAI S, Mochizuki H, Kojima Y, Nakagomi K, et al
    Validation of Tokyo Guideline 2013 as Treatment of Acute Cholecystitis by Real World Data.
    Dig Dis. 2019 Feb 7:1-6. doi: 10.1159/000496738.
    PubMed     Text format     Abstract available


    January 2019
  2. OGURA T, Imoto A, Okuda A, Fukunishi S, et al
    Can Iodixanol Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis? A Prospective, Randomized, Controlled Trial.
    Dig Dis. 2019 Jan 17:1-7. doi: 10.1159/000496349.
    PubMed     Text format     Abstract available


    October 2018
  3. CHANDRA S, Klair JS, Soota K, Livorsi DJ, et al
    Endoscopic Retrograde Cholangio-Pancreatography-Obtained Bile Culture Can Guide Antibiotic Therapy in Acute Cholangitis.
    Dig Dis. 2018 Oct 3:1-6. doi: 10.1159/000493579.
    PubMed     Text format     Abstract available


    September 2018
  4. NENNSTIEL S, Treiber M, Faber A, Haller B, et al
    Comparison of Ultrasound and Fluoroscopically Guided Percutaneous Transhepatic Biliary Drainage.
    Dig Dis. 2018 Sep 25:1-10. doi: 10.1159/000493120.
    PubMed     Text format     Abstract available


    August 2018
  5. OGURA T, Miyano A, Nishioka N, Higuchi K, et al
    Recanalization for Tight Bile Duct-Jejunum Anastomosis Stricture Using Peroral Transliminal Cholangioscopy (with Video).
    Dig Dis. 2018 Aug 28:1-4. doi: 10.1159/000490737.
    PubMed     Text format     Abstract available


    May 2018
  6. LOOSEN SH, Vucur M, Trautwein C, Roderburg C, et al
    Circulating Biomarkers for Cholangiocarcinoma.
    Dig Dis. 2018 May 15:1-8. doi: 10.1159/000488342.
    PubMed     Text format     Abstract available


    April 2018
  7. SHEN J, Wen T, Li C, Yan L, et al
    The Prognostic Prediction Role of Preoperative Serum Albumin Level in Patients with Intahepatic Cholangiocarcinoma Following Hepatectomy.
    Dig Dis. 2018 Apr 19. pii: 000487479. doi: 10.1159/000487479.
    PubMed     Text format     Abstract available


    May 2017
  8. PENG X, Luo X, Hou JY, Wu SY, et al
    Immunosuppressive Agents for the Treatment of Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis.
    Dig Dis. 2017 May 6. doi: 10.1159/000471874.
    PubMed     Text format     Abstract available


    March 2017
  9. KIM HJ, Kim JS, Oh S, Yoo HS, et al
    Inhibition of Ceramide Decreased the Expression of ATP-Binding Cassette Transporter G5/8 mRNA in an Animal Model of Cholesterol Gallstone.
    Dig Dis. 2017 Mar 8. doi: 10.1159/000465517.
    PubMed     Text format     Abstract available


    January 2017
  10. SLIJEPCEVIC D, van de Graaf SF
    Bile Acid Uptake Transporters as Targets for Therapy.
    Dig Dis. 2017;35:251-258.
    PubMed     Text format     Abstract available


  11. CAI SY, Boyer JL
    The Role of Inflammation in the Mechanisms of Bile Acid-Induced Liver Damage.
    Dig Dis. 2017;35:232-234.
    PubMed     Text format     Abstract available


  12. JOYCE SA, Gahan CG
    Disease-Associated Changes in Bile Acid Profiles and Links to Altered Gut Microbiota.
    Dig Dis. 2017;35:169-177.
    PubMed     Text format     Abstract available


  13. KEPPLER D
    Progress in the Molecular Characterization of Hepatobiliary Transporters.
    Dig Dis. 2017;35:197-202.
    PubMed     Text format     Abstract available


  14. CHANG JC, Beuers U, Oude Elferink RP
    The Emerging Role of Soluble Adenylyl Cyclase in Primary Biliary Cholangitis.
    Dig Dis. 2017;35:217-223.
    PubMed     Text format     Abstract available


  15. DAWSON PA
    Roles of Ileal ASBT and OSTalpha-OSTbeta in Regulating Bile Acid Signaling.
    Dig Dis. 2017;35:261-266.
    PubMed     Text format     Abstract available


  16. PERUGORRIA MJ, Labiano I, Esparza-Baquer A, Marzioni M, et al
    Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment.
    Dig Dis. 2017;35:275-281.
    PubMed     Text format     Abstract available


  17. LARUSSO NF, Tabibian JH, O'Hara SP
    Role of the Intestinal Microbiome in Cholestatic Liver Disease.
    Dig Dis. 2017;35:166-168.
    PubMed     Text format     Abstract available


  18. REICH M, Klindt C, Deutschmann K, Spomer L, et al
    Role of the G Protein-Coupled Bile Acid Receptor TGR5 in Liver Damage.
    Dig Dis. 2017;35:235-240.
    PubMed     Text format     Abstract available


  19. SASAKI M, Nakanuma Y
    Bile Acids and Deregulated Cholangiocyte Autophagy in Primary Biliary Cholangitis.
    Dig Dis. 2017;35:210-216.
    PubMed     Text format     Abstract available


  20. WAHLSTROM A, Kovatcheva-Datchary P, Stahlman M, Backhed F, et al
    Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling.
    Dig Dis. 2017;35:246-250.
    PubMed     Text format     Abstract available


  21. HEGADE VS, Jones DE, Hirschfield GM
    Apical Sodium-Dependent Transporter Inhibitors in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Dig Dis. 2017;35:267-274.
    PubMed     Text format     Abstract available


  22. STEINACHER D, Claudel T, Trauner M
    Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver Disease.
    Dig Dis. 2017;35:282-287.
    PubMed     Text format     Abstract available


  23. HALILBASIC E, Steinacher D, Trauner M
    Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver Diseases.
    Dig Dis. 2017;35:288-292.
    PubMed     Text format     Abstract available


  24. GALLE PR
    Treating Hepatobiliary Cancers: The Oncology Way.
    Dig Dis. 2017;35:384-386.
    PubMed     Text format     Abstract available


  25. WONG LL, Hegade VS, Jones DEJ
    What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis?
    Dig Dis. 2017;35:359-366.
    PubMed     Text format     Abstract available


  26. DUFFY AG, Greten TF
    Treating Hepatobiliary Cancer: The Immunologic Approach.
    Dig Dis. 2017;35:390-396.
    PubMed     Text format     Abstract available


  27. IWAMOTO T, Imai Y, Igura T, Kogita S, et al
    Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellula
    Dig Dis. 2017;35:574-582.
    PubMed     Text format     Abstract available


    January 2016
  28. WEILER-NORMANN C, Lohse AW
    Variant Syndromes of Autoimmune Liver Diseases: Classification, Diagnosis and Management.
    Dig Dis. 2016;34:334-9.
    PubMed     Text format     Abstract available


  29. ARNDTZ K, Hirschfield GM
    The Pathogenesis of Autoimmune Liver Disease.
    Dig Dis. 2016;34:327-33.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Biliary Tract Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: